Strategic 1-multi-line therapy trial in unresectable wild-type RAS metastatic colorectal cancer
: A gercor randomized open-label phase III study.
Benoist Chibaudel
Consultant or Advisory Role - Roche
Christophe Tournigand
No relevant relationships to disclose
Franck Bonnetain
Honoraria - Bristol-Myers Squibb; Merck; Roche
Research Funding - Roche
Marine Hug de larauze
No relevant relationships to disclose
Armand De Gramont
No relevant relationships to disclose
Pierre Laurent-Puig
Consultant or Advisory Role - Amgen; IntegraGen; Merck Serono
Christophe Louvet
Honoraria - Merck; Roche/Genentech
Thierry André
Consultant or Advisory Role - Amgen; Merck; Roche
Honoraria - Amgen; Merck; Roche
Aimery De Gramont
Consultant or Advisory Role - Roche
Honoraria - Roche